We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Karo Bio Announces that Merck & Co. Plans to Proceed With Phase II Clinical Evaluation of Candidate Compound

News   Nov 27, 2009

 
Karo Bio Announces that Merck & Co. Plans to Proceed With Phase II Clinical Evaluation of Candidate Compound
 
 
 

RELATED ARTICLES

Discovering the Parameters That Govern the Encapsulation of Drugs

News

Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs.

READ MORE

New Class of Drugs Could Treat Ovarian Cancer

News

A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

READ MORE

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE